Administration announces initiative to speed development, distribution of COVID-19 vaccines, therapeutics and diagnostics
The Trump administration Friday introduced Operation Warp Speed, a $10 billion public-private partnership intended to accelerate development, manufacturing and distribution of COVID-19 vaccines, therapeutics and diagnostics by January 2021.
The White House said the federal government will oversee treatment trial protocols, lead the selection of manufacturing partners and work on a distribution plan that includes necessary materials, such as vials and appropriate storage.
As a condition of receiving support from Operation Warp Speed, companies will provide donated allocations of countermeasures developed, including an eventual vaccine.
Related News Articles
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…